786 results on '"Hoffman, Gary S."'
Search Results
2. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
3. Single-Organ Genitourinary Vasculitis
4. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
5. Surgical subspecialists in West Africa: Workforce size, training opportunities, and contributing factors
6. Single-Organ Genitourinary Vasculitis
7. Meta‐analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis
8. Face Transplantation for Granulomatosis With Polyangiitis (Wegener Granulomatosis): Technical Considerations, Immunological Aspects, and 3-Year Posttransplant Outcome
9. Vasculitic Emergencies in Patients with Large-Vessel Vasculitis
10. Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission
11. Methotrexate as an alternative to classic immunosuppressive therapies
12. The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
13. Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
14. IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis
15. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type
16. Limited Prognostic Value of Changes in Antineutrophil Cytoplasmic Antibody Titers in Patients with Wegener’s Granulomatosis
17. Treatment of Chronic Idiopathic Systemic Vasculitides
18. Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.
19. The Divine Attributes
20. Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA‐Associated Vasculitis
21. Research Productivity of Surgical Subspecialists of the West African College of Surgeons
22. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis
23. Reply
24. 14–3–3 in Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis
25. Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
26. Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study
27. Peripheral CD5+ B Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
28. Rituximab versus cyclophosphamide for ANCA-associated vasculitis
29. Aortitis: Outcomes from a Cohort of 196 Patients.: 2786
30. Rituximab With or Without a Conventional Maintenance Agent in the Treatment of Relapsing Granulomatosis With Polyangiitis (Wegenerʼs): A Retrospective Single-Center Study
31. Vasculitis: determinants of disease patterns
32. An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegenerʼs)
33. Brief Report: The Value of a Patient Global Assessment of Disease Activity in Granulomatosis With Polyangiitis (Wegenerʼs)
34. Contributors
35. Takayasu's Arteritis
36. Systemic Vasculitis in Sarcoidosis
37. Single Organ Vasculitis
38. Granulomatosis with Polyangiitis (Wegener's)
39. Association of Granulomatosis With Polyangiitis (Wegenerʼs) With HLA–DPB1*04 and SEMA6A Gene Variants: Evidence Grom Genome-Wide Analysis
40. Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
41. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis
42. Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody–associated vasculitis: Comment on the article by Faurschou et al
43. List of Contributors
44. Vasculitis
45. Contributors
46. Polymyalgia Rheumatica and Giant Cell Arteritis
47. Takayasu's Arteritis
48. Long-Term Outcome of Patients with Granulomatosis with Polyangiitis (Wegenerʼs) Treated with Rituximab.: 1544
49. Distribution of arterial lesions in Takayasuʼs arteritis and giant cell arteritis
50. Estradiol enhances endothelial cell interactions with extracellular matrix proteins via an increase in integrin expression and function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.